| Literature DB >> 31662994 |
Aleksandra Żebrowska1, Dariusz Jastrzębski2, Ewa Sadowska-Krępa1, Marcin Sikora1, Camillo Di Giulio3.
Abstract
AIMS: The study investigated the effect of high-intensity interval training in hypoxia and normoxia on serum concentrations of proangiogenic factors, nitric oxide, and inflammatory responses in healthy male volunteers.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31662994 PMCID: PMC6778879 DOI: 10.1155/2019/7315714
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Subject's anthropometric characteristics.
| Variable |
|
|---|---|
| Age (yr) | 24.4 (4.0) |
| Body height (cm) | 180.6 (5.9) |
| Body weight (kg) | 72.2 (4.4) |
| BMI (kg/m2) | 21.8 (1.2) |
| HRrest (1/min) | 54.2 (2.6) |
| SBPrest (mm Hg) | 120.0 (15.0) |
| DBPpre (mm Hg) | 77.0 (5.0) |
| VO2max (mL/kg/min) | 54.2 (2.6) |
Data are means and SD.
Maximal oxygen uptake (VO2max) and physiological results before and after training in both training groups.
| Variables | Pretraining | Posttraining |
| 95% confidence interval for differences | ||||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean differences | Lower bound | Upper bound | ||
|
| ||||||||
| VO2max (mL/kg/min) | 53.2 | 2.6 | 59.4 | 4.6 | 0.01 | 6.2 | −8.9 | −2.7 |
| LAmax (mmol/L) | 11.1 | 1.8 | 10.4 | 1.5 | 0.06 | −0.7 | 0.1 | 1.3 |
| VEmax (L/min) | 163.2 | 9.6 | 166.9 | 13.8 | 0.05 | 3.7 | −12.2 | −2.2 |
| HRmax (1/min) | 189.0 | 8.0 | 191.0 | 4.0 | 0.07 | 2.0 | 0.1 | 2.8 |
| SBPmax (mm Hg) | 160.0 | 12.0 | 162.0 | 13.0 | 0.11 | 2.0 | −14.1 | −4.1 |
| DBPmax (mm Hg) | 77.0 | 8.0 | 72.0 | 6.0 | 0.06 | −5.0 | −11.2 | −2.4 |
| SatO2max (%) | 94.8 | 3.6 | 91.5 | 2.4 | 0.01 | −3.3 | 0.8 | 4.4 |
| pO2max (mmHg) | 88.3 | 1.7 | 68.2 | 1.2 | 0.01 | −20.1 | 17.3 | 22.7 |
| pCO2max (mmHg) | 34.1 | 1.7 | 33.4 | 1.2 | 0.05 | −0.7 | −0.4 | 1.2 |
|
| 277.3 | 16.1 | 293.6 | 15.7 | 0.05 | 16.4 | −30.2 | −2.5 |
|
| ||||||||
|
| ||||||||
| VO2max (mL/kg/min) | 54.2 | 2.6 | 55.4 | 4.8 | 0.47 | 1.2 | −2.9 | 1.4 |
| LAmax (mmol/L) | 11.2 | 1.8 | 10.6 | 1.6 | 0.33 | −0.6 | −0.3 | 0.9 |
| VEmax (L/min) | 160.4 | 12.5 | 165.4 | 13.0 | 0.05 | 5.0 | −7.8 | −1.5 |
| HRmax (1/min) | 190.0 | 6.0 | 191.0 | 3.0 | 0.06 | 1.0 | −4.0 | 0.1 |
| SBPmax (mm Hg) | 156.0 | 10.0 | 155.0 | 9.0 | 1.00 | −1.0 | −8.9 | −4.1 |
| DBPmax (mm Hg) | 77.0 | 8.0 | 76.0 | 8.0 | 0.91 | −1.0 | −4.8 | −3.7 |
| SatO2max (%) | 98.8 | 3.6 | 96.8 | 4.1 | 0.08 | −2.0 | 1.8 | 3.1 |
| pO2max (mmHg) | 88.3 | 1.7 | 87.8 | 1.8 | 0.17 | −0.5 | −0.2 | 1.4 |
| pCO2max (mmHg) | 35.1 | 1.7 | 34.2 | 1.3 | 0.08 | −0.9 | −0.4 | 1.2 |
|
| 280.1 | 15.1 | 290.0 | 9.2 | 0.06 | 18.9 | −31.6 | −4.8 |
Hematological results before and after training in both training groups.
| Variables | Pretraining | Posttraining |
| 95% confidence interval for differences | ||||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean differences | Lower bound | Upper bound | ||
|
| ||||||||
| LYM (109/L) | 2.1 | 0.9 | 2.2 | 0.5 | 0.28 | 0.1 | −0.5 | −0.1 |
| ANC (109/L) | 2.5 | 0.7 | 3.2 | 1.2 | 0.04 | 0.7 | −1.4 | 0.6 |
| MON (109/L) | 0.6 | 0.3 | 0.5 | 0.3 | 0.25 | −0.1 | −0.1 | 0.2 |
| WBC (109/L) | 5.2 | 1.7 | 5.8 | 1.1 | 0.04 | 0.6 | −1.4 | 0.4 |
| HGB (g/L) | 15.4 | 2.1 | 15.8 | 0.6 | 0.02 | 0.4 | −0.6 | −0.2 |
| HCT (%) | 44.8 | 1.8 | 45.3 | 2.1 | 0.04 | 0.5 | −0.9 | 0.1 |
| RBC (1012/L) | 5.0 | 0.8 | 5.2 | 0.4 | 0.06 | 0.2 | −0.4 | 0 |
| RET (%) | 1.0 | 0.2 | 1.2 | 0.2 | 0.05 | 0.2 | −0.2 | −0.1 |
|
| ||||||||
|
| ||||||||
| LYM (109/L) | 2.1 | 0.6 | 2.1 | 0.7 | 0.69 | 0 | −0.1 | 0.1 |
| ANC (109/L) | 2.4 | 0.8 | 2.1 | 1.6 | 0.14 | −0.3 | −0.1 | 0.6 |
| MON (109/L) | 0.6 | 0.2 | 0.7 | 0.3 | 0.05 | 0.1 | −0.2 | 0 |
| WBC (109/L) | 5.1 | 1.9 | 5.2 | 2.0 | 0.66 | 0.1 | −0.8 | 0.5 |
| HGB (g/L) | 15.3 | 1.0 | 15.1 | 0.9 | 0.16 | −0.2 | −0.1 | 0.3 |
| HCT (%) | 44.2 | 2.0 | 44.0 | 2.8 | 0.94 | 0.2 | −0.8 | 0.8 |
| RBC (1012/L) | 5.1 | 0.4 | 5.0 | 0.2 | 0.38 | −0.1 | −0.1 | 0.2 |
| RET (%) | 1.1 | 0.1 | 1.0 | 0.1 | 1.00 | −0.1 | 0 | 0 |
Figure 1Hypoxia-inducible factor-1-alpha (HIF-1α) pretraining (preTr) and posttraining (postTr) levels at rest and at maximal exercise test (max) in normoxia and hypoxia. Data are means and SD. p < 0.01, significant difference between preTr and postTr; #p < 0.05, ##p < 0.01, significant difference between normoxia and hypoxia.
Figure 2Nitric oxide (NO) pretraining (preTr) and posttraining (postTr) levels at rest and at maximal exercise test (max) in normoxia and hypoxia. Data are means and SD. p < 0.01, significant difference between preTr and postTr; #p < 0.05, significant difference between normoxia and hypoxia.
Angiogenic factors and cytokine results before and after training in both training groups.
| Variables | Pretraining | Posttraining |
| 95% confidence interval for differences | ||||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean differences | Lower bound | Upper bound | ||
|
| ||||||||
| HIF-1 | 16.6 | 7.8 | 32.2 | 5.2 | 0.02 | 15.6 | −20.2 | −9.6 |
| HIF-1 | 36.5 | 11.2 | 98.0 | 16.4 | 0.01 | 61.5 | −74.7 | −47.3 |
| NOrest ( | 11.5 | 3.8 | 13.1 | 3.8 | 0.01 | 1.6 | −2.4 | −0.4 |
| NOmax( | 12.8 | 6.1 | 15.9 | 6.0 | 0.05 | 3.1 | −7.3 | 0.5 |
| ADMArest ( | 0.4 | 0.2 | 0.6 | 0.1 | 0.06 | 0.2 | −0.3 | −0.02 |
| ADMAmax ( | 0.7 | 0.3 | 0.6 | 0.3 | 0.07 | −0.1 | 0 | 0.4 |
| VEGFrest (pg/mL) | 15.9 | 8.4 | 20.6 | 7.5 | 0.10 | 4.7 | −9.9 | 1.0 |
| VEGFmax (pg/mL) | 9.5 | 6.7 | 17.6 | 8.1 | 0.04 | 8.1 | −16.1 | −0.4 |
| TGF- | 118.5 | 10.8 | 134.6 | 19.4 | 0.02 | 16.1 | −23.0 | −9.2 |
| TGF- | 129.4 | 22.6 | 158.0 | 34.8 | 0.01 | 28.6 | −48.4 | −8.6 |
| TNF- | 24.2 | 9.8 | 35.7 | 14.2 | 0.07 | 11.5 | −16.8 | −5.3 |
| TNF- | 36.5 | 11.0 | 42.3 | 18.1 | 0.12 | 5.8 | −13.8 | 1.8 |
| IL-6rest (pg/mL) | 1.3 | 0.6 | 1.9 | 1.5 | 0.06 | 0.6 | −1.3 | −0.2 |
| IL-6max (pg/mL) | 1.4 | 0.7 | 2.1 | 1.3 | 0.06 | −0.1 | −1.1 | −0.1 |
| IL-1 | 3.1 | 1.9 | 5.9 | 3.6 | 0.06 | 2.8 | −4.2 | −2.0 |
| IL-1 | 3.8 | 2.0 | 8.1 | 3.6 | 0.01 | 4.3 | −0.3 | 0.2 |
|
| ||||||||
|
| ||||||||
| HIF-1 | 18.6 | 8.1 | 20.1 | 10.7 | 0.61 | 1.5 | −8.0 | 4.9 |
| HIF-1 | 30.1 | 10.4 | 37.6 | 11.1 | 0.05 | 7.5 | −10.8 | −2.4 |
| NOrest ( | 12.7 | 4.2 | 10.7 | 3.8 | 0.06 | −2.0 | 1.0 | 3.1 |
| NOmax( | 13.8 | 5.1 | 12.5 | 4.0 | 0.90 | −1.3 | −0.4 | 4.2 |
| ADMArest ( | 0.5 | 0.3 | 0.5 | 0.2 | 0.34 | 0 | −0.1 | 0.0 |
| ADMAmax ( | 0.6 | 0.4 | 0.7 | 0.2 | 0.85 | 0.1 | −0.2 | 0.2 |
| VEGFrest (pg/mL) | 17.2 | 14.1 | 22.6 | 15.8 | 0.27 | 5.4 | −13.1 | 4.1 |
| VEGFmax (pg/mL) | 8.4 | 7.3 | 17.4 | 11.3 | 0.03 | 9.0 | −18.6 | −0.9 |
| TGF- | 121.5 | 18.8 | 131.0 | 18.8 | 0.18 | 9.5 | −19.9 | 4.3 |
| TGF- | 127.8 | 27.0 | 143.0 | 42.0 | 0.04 | 15.2 | −26.6 | 14.8 |
| TNF- | 24.2 | 9.8 | 35.1 | 10.4 | 0.06 | 10.9 | −16.1 | −5.1 |
| TNF- | 34.8 | 10.3 | 34.3 | 7.7 | 0.91 | −0.5 | −6.8 | 7.6 |
| IL-6rest (pg/mL) | 1.2 | 0.8 | 0.9 | 0.6 | 0.22 | −0.3 | −0.2 | 0.8 |
| IL-6max (pg/mL) | 1.3 | 0.9 | 1.1 | 1.0 | 0.21 | −0.2 | −0.1 | 0.6 |
| IL-1 | 3.3 | 2.0 | 3.1 | 3.3 | 0.72 | −0.2 | −0.6 | 0.9 |
| IL-1 | 3.5 | 2.6 | 3.3 | 1.7 | 0.03 | −0.2 | −0.5–2 | 0.4 |